No worries tomagi.
Regarding the question about using option, I only looked at them briefly and decided to just buy shares. I did notice that there are weeklies on GILD which I sometimes uses for generating income on a weekly basis. I’m also low on cash so I may decide to add to my position by selling deep in the money puts. If I do I’ll probably look at the Jan15 $100 puts first.
Regarding drug pricing being high, I’m not concerned about it. One should really also look at the other side of the equation: what economic benefits are gained by curing a person of HepC! For starters, there are direct reductions in future healthcare costs for that person, possibly avoiding a liver transplant. I’m sure GILD did a thorough examination of the pharmacoeconomics of Solvaldi befor pricing it.
Chris